CONCOMITANT CORTICOSTEROID USE WITH RAVULIZUMAB IN ADULTS WITH ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY-POSITIVE GENERALIZED MYASTHENIA GRAVIS: PHASE 3 CHAMPION-MG OPENLABEL EXTENSION FINAL RESULTS

被引：0
|
作者：
Nicolle, Michael
Annane, Djillali
Meisel, Andreas
Vu, Tuan
Mantegazza, Renato
Katsuno, Masahisa
Bril, Vera
Aguzzi, Rasha
Frick, Glen
Howard, James F., Jr.
机构：
来源：
MUSCLE & NERVE | 2024年 / 70卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
236
引用
收藏
页码：574 / 575
页数：2
相关论文
共 28 条
  • [21] Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebocontrolled, multicentre study (vol 16, pg 976, 2017)
    Howard, J. F., Jr.
    Utsugisawa, K.
    Benatar, M.
    LANCET NEUROLOGY, 2017, 16 (12): : 954 - 954
  • [22] Pharmacokinetics and Pharmacodynamics of Ravulizumab in Adults with Anti-Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder During the Phase 3 CHAMPION-NMOSD trial
    Ortiz, Stephan
    Pittock, Sean
    Berthele, Achim
    Levy, Michael
    Nakashima, Ichiro
    Guevara, Celia Oreja
    Kim, Ho Jin
    NEUROLOGY, 2023, 100 (17)
  • [23] Efficacy and safety of ravulizumab in adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: outcomes from the phase 3 CHAMPION-NMOSD trial
    Pittock, S. J.
    Barnett, M.
    Bennett, J. L.
    Berthele, A.
    de Seze, J.
    Levy, M.
    Nakashima, I.
    Oreja-Guevara, C.
    Palace, J.
    Paul, F.
    Pozzilli, C.
    Allen, K.
    Mashhoon, Y.
    Yountz, M.
    Kim, H. J.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 39 - 40
  • [24] Efficacy and safety of ravulizumab in adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: Outcomes from the phase 3 CHAMPION-NMOSD trial
    Pittock, Sean
    Barnett, Michael
    Bennett, Jeffrey
    Berthele, Achim
    De Seze, Jerome
    Levy, Michael
    Nakashima, Ichiro
    Oreja-Guevara, Celia
    Palace, Jacqueline
    Paul, Friedemann
    Pozzilli, Carlo
    Allen, Kerstin
    Mashhoon, Yasmin
    Yountz, Marcus
    Kim, Ho Jin
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [25] Efficacy and Safety of Ravulizumab in Adults With Anti-aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Outcomes From the Phase 3 CHAMPION-NMOSD Trial
    Kim, Ho Jin
    Barnett, Michael
    Bennett, Jeffrey
    Berthele, Achim
    de Seze, Jerome
    Levy, Michael
    Nakashima, Ichiro
    Oreja-Guevara, Celia
    Palace, Jacqueline
    Paul, Friedemann
    Pozzilli, Carlo
    Allen, Kerstin
    Mashhoon, Yasmin
    Yountz, Marcus
    Pittock, Sean
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (07) : NP30 - NP31
  • [26] Efficacy and safety of ravulizumab in adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: outcomes from the phase 3 CHAMPION-NMOSD trial
    Pittock, Sean
    Barnett, Michael
    Bennett, Jeffrey
    Berthele, Achim
    De Seze, Jerome
    Levy, Michael
    Nakashima, Ichiro
    Guevara, Celia Oreja
    Palace, Jacqueline
    Paul, Friedemann
    Pozzilli, Carlo
    Allen, Kerstin
    Mashhoon, Yasmin
    Yountz, Marcus
    Kim, Ho Jin
    NEUROLOGY, 2023, 100 (17)
  • [27] Long-term efficacy and safety of ravulizumab in adults with AChR-Ab plus gMG: final results from the phase 3 CHAMPION MG open-label extension
    Vu, T.
    Mantegazza, R.
    Annane, D.
    Katsuno, M.
    Meisel, A.
    Nicolle, M.
    Bril, V.
    Aguzzi, R.
    Frick, G.
    Howard, J., Jr.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [28] Infection Risk in Patients with Complement-Mediated Neurological Disorders Receiving Eculizumab: Findings from Two Phase 3 Studies and Their Extensions in Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder (AQP4+NMOSD) and Acetylcholine-Receptor Antibody-Positive Refractory Generalized Myasthenia Gravis (AChR plus gMG)
    Levine, Todd
    Mantegazza, Renato
    Oreja-Guevara, Celia
    Carrillo-Infante, Cynthia
    Kaprielian, Roger
    Shang, Shulian
    Yountz, Marcus
    Howard, James
    NEUROLOGY, 2020, 94 (15)
123